NICTUR Trademark

Trademark Overview


On Wednesday, September 29, 2010, a trademark application was filed for NICTUR with the United States Patent and Trademark Office. The USPTO has given the NICTUR trademark a serial number of 79088593. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, November 30, 2017. This trademark is owned by GP PHARM, S.A.. The NICTUR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, in particular for use in nighttime or daytime enuresis, Willebrand-Jurgen's syndrome, hemorrhaging, diabetes insipidus, for use in oncology, for treating cancer, for treating cardiovascular diseases, antivirals, for treating inflammatory diseases of the intestine, for treating inflammatory diseases of the connective tissue, for treating arthritis, for treating urological diseases, for treating psychiatric diseases, in particular mood disorders, anxiety disorders, cognitive disorders, schizophrenia, for treating neurological and neurodegenerative diseases and disorders, in particular, dementia linked to Alzheimer's disease, Huntington's disease, Parkinson's disease, cerebral palsy, brain injuries and diseases, injuries and diseases of the spinal cord, convulsive disorders, epilepsy, encephalitis, disorders of the central nervous system, ocular motility disorders, dystonia, blepharospasm, strabismus, facial scoliosis and tics, cerebral ischemia,...
nictur

General Information


Serial Number79088593
Word MarkNICTUR
Filing DateWednesday, September 29, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, November 30, 2017
Registration Number3964633
Registration DateTuesday, May 24, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2011

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use, in particular for use in nighttime or daytime enuresis, Willebrand-Jurgen's syndrome, hemorrhaging, diabetes insipidus, for use in oncology, for treating cancer, for treating cardiovascular diseases, antivirals, for treating inflammatory diseases of the intestine, for treating inflammatory diseases of the connective tissue, for treating arthritis, for treating urological diseases, for treating psychiatric diseases, in particular mood disorders, anxiety disorders, cognitive disorders, schizophrenia, for treating neurological and neurodegenerative diseases and disorders, in particular, dementia linked to Alzheimer's disease, Huntington's disease, Parkinson's disease, cerebral palsy, brain injuries and diseases, injuries and diseases of the spinal cord, convulsive disorders, epilepsy, encephalitis, disorders of the central nervous system, ocular motility disorders, dystonia, blepharospasm, strabismus, facial scoliosis and tics, cerebral ischemia, dementia, amyotrophic sclerosis, and lateral multiple sclerosis, for treating auto-immune diseases, for treating transplant rejection, for treating ophthalmological diseases such as proliferative or non-proliferative diabetic retinopathy, macular degeneration, age-related macular degeneration, retinal neovascularization, neovascularization associated with choroidal melanoma, retinopathy, central retinal vein occlusion, pigmentary retinitis, uveitis, macular edema, cystoid macular edema, peptides

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, November 30, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGP PHARM, S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressES

Party NameGP PHARM, S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES

Party NameGP PHARM, S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events


Event DateEvent Description
Monday, October 19, 2020INTERNATIONAL REGISTRATION RENEWED
Friday, June 7, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 23, 2018NOTIFICATION PROCESSED BY IB
Friday, April 13, 2018REFUSAL PROCESSED BY IB
Friday, December 15, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, December 15, 2017DEATH OF INTERNATIONAL REGISTRATION
Friday, August 14, 2015NEW REPRESENTATIVE AT IB RECEIVED
Sunday, October 2, 2011NOTIFICATION PROCESSED BY IB
Tuesday, August 2, 2011FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, August 2, 2011FINAL DISPOSITION PROCESSED
Thursday, June 23, 2011GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, May 24, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, March 8, 2011PUBLISHED FOR OPPOSITION
Thursday, March 3, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, March 3, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 16, 2011NOTICE OF PUBLICATION
Friday, January 14, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, January 9, 2011ASSIGNED TO EXAMINER
Saturday, November 20, 2010APPLICATION FILING RECEIPT MAILED
Tuesday, November 16, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 12, 2010LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 11, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB